UN Statistics Division · Health

Libya: Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine

89Percentage · 2024+128.2% since 2014

UN SDG Global Database series SH_ACS_PCV3, for SDG indicator 3.b.1. Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (Percentage). Annual figures for Libya from 2014 to 2024.

20142024

Every year

YearValue (Percentage)Note
202489
202373
202273
202173
202073
201973
201872
201795
201696
201571
201439

Source

Published by UN Statistics Division, produced by UN Statistics Division. Licence: UN terms of use (reuse with attribution). Retrieved 2026-11-15.

The dataset for every country, with quality and provenance →

Cite or download

UN Statistics Division (2026). Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine. Interva. https://interva.co/dataset/unsdg-sh-acs-pcv3-percent (accessed 2026-11-18). catalog snapshot 2026-11-15.

JSON, LibyaAPI and MCP

Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine in other countries

Rank Libya against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Libya: Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (2014–2024) · Interva